Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVEYLQIKGA        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
N
HLA I Alleles
(ProPred I)
HLA-B40, HLA-B*4403, HLA-B*51, HLA-B*5401, HLA-B60, HLA-B61, MHC-Kk7
HLA I Alleles
(nHLAPred)
NA0
HLA II Alleles
(PrePred)
DRB1_1101, DRB1_1102, DRB1_1104, DRB1_1106, DRB1_1121, DRB1_1307, DRB1_1311, DRB1_13228
B_Cell_Epitope
(ABCPred)
N

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package